At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
NaturalVue Multifocaldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Extended Depth of Focus Contact Lenses for Presbyopia
In Brief
A clinical study evaluating NaturalVue Multifocal for Presbyopia. Completed, enrolled 24 participants across 1 site.
Detailed Summary
VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedAug 2022
Enrollment StartSep 2022
Primary CompletionMay 2023
TodayJul 2026
First PostedAug 10, 2022
Enrollment StartSep 6, 2022
Primary CompletionMay 12, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.9 years ago
Interventions
NaturalVue Multifocaldevice
EDOF